Siu Wing Fung Alfred 4

What Happened

• Siu Wing Fung Alfred, Chairman, CEO and a director of NewGenIvf Group Ltd (NIVF), received a grant of 56,851 stock options on May 4, 2026. The Form 4 reports this as a derivative award (transaction code A); the recorded acquisition value is $0. The options have an exercise price of US$0.0001 per share.

Key Details

• Transaction date: 2026-05-04; Form 4 filed: 2026-05-06 (appears timely).
• Grant size: 56,851 options; exercise price: $0.0001 per option (aggregate exercise cost if fully exercised ≈ $5.69).
• Vesting: 5,685 options vest 4 June 2026; then 1,462 options vest on the 4th of each month from 4 July 2026 through 4 April 2029 (34 monthly tranches); final 1,458 options vest 4 May 2029.
• Expiration: Options expire 4 May 2033, subject to the Option Agreement and the 2024 Share Incentive Plan.
• Shares owned after transaction: not specified in the filing.
• Footnote: Grant made under the Issuer’s 2024 Share Incentive Plan and an Option Agreement dated 4 May 2026.

Context

• This is a grant of options (an award), not an immediate purchase or sale of shares. It does not reflect an exercised option or a sale of shares — the holder must wait for vesting and then exercise (pay the exercise price) to obtain shares.
• Option grants to executives are commonly used for long-term incentive alignment and should be interpreted as compensation rather than an immediate market bet.